Laird Norton Wetherby Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.07M | Buy |
|
|||||
|
2025
Q2 | $3.28M | Buy |
|
|||||
|
2024
Q4 | $2.28M | Sell |
|
|||||
|
2024
Q3 | $2.36M | Buy |
|
|||||
|
2024
Q2 | $2.12M | Sell |
|
|||||
|
2024
Q1 | $1.95M | Buy |
|
|||||
|
2023
Q4 | $1.63M | Sell |
|
|||||
|
2023
Q3 | $1.49M | Buy |
|
|||||
|
2023
Q2 | $1.5M | Sell |
|
|||||
|
2023
Q1 | $1.43M | Sell |
|
|||||
|
2022
Q4 | $1.35M | Buy |
|
|||||
|
2022
Q3 | $1.1M | Buy |
|
|||||
|
2022
Q2 | $1.04M | Buy |
|
|||||
|
2022
Q1 | $1.14M | Buy |
|
|||||
|
2021
Q4 | $1M | Sell |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $881K | Sell |
|
|||||
|
2020
Q4 | $824K | Sell |
|
|||||
|
2020
Q3 | $965K | Buy |
|
|||||
|
2020
Q2 | $768K | Sell |
|
|||||
|
2020
Q1 | $724K | Sell |
|
|||||
|
2019
Q4 | $1.05M | Buy |
|
|||||
|
2019
Q3 | $871K | Buy |
|
|||||
|
2019
Q2 | $898K | Buy |
|
|||||
|
2019
Q1 | $782K | Buy |
|
|||||
|
2018
Q4 | $625K | Buy |
|
|||||
|
2018
Q3 | $673K | Buy |
|
|||||
|
2018
Q2 | $549K | Buy |
|
|||||
|
2018
Q1 | $420K | Buy |
|
|||||
|
2017
Q4 | $362K | Buy |
|
|||||
|
2017
Q3 | $408K | Buy |
|
|||||
|
2017
Q2 | $382K | Buy |
|
|||||
|
2017
Q1 | $330K | Buy |
|
|||||
|
2016
Q4 | $269K | Sell |
|
|||||
|
2016
Q3 | $328K | Buy |
|
|||||
|
2016
Q2 | $312K | Buy |
|
|||||
|
2016
Q1 | $226K | Buy |
|
|||||
|
2015
Q4 | $210K | Buy |
|
|||||
|
2015
Q3 | $183K | Buy |
|
|||||
|
2015
Q2 | $188K | Buy |
|